The SGLT2 inhibitor luseogliflozin rapidly normalizes aortic mRNA levels of inflammation-related but not lipid-metabolism-related genes and suppresses atherosclerosis in diabetic ApoE KO mice - Nakatsu, Y; Kokubo, H; Bumdelger, B (Int J Mol Sci, 2017)